Skip to main content
Retour
Watch Compare

ABEONA THERAPEUTICS INC.

Qualité des données : 100%
ABEO
Nasdaq Manufacturing Chemicals
4,91 €
▼ 0,21 € (-4,10%)
Cap. Boursière: 294,66 M
Prix
5,17 €
Cap. Boursière
294,66 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 18,02% annually over 5 years — strong growth
ROE of 42,52% indicates high profitability
Net margin of 1223,08% shows strong profitability
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -84,30 M
P/E of 4,14 — trading at a low valuation

Croissance

Revenue Growth (5Y)
18,02%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)66,29%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
42,52%
Au-dessus de la moyenne du secteur (-53,47%)
ROIC-42,47%
Net Margin1223,08%
Op. Margin-1536,91%

Sécurité

Debt / Equity
0,12
En dessous de la moyenne du secteur (0,30)
Current Ratio9,74
Interest Coverage-23,92

Valorisation

PE (TTM|2027)
4,14 | 21,54
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio1,72
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 4,1 -1,5
P/B 1,7 1,6
ROE % 42,5 -53,5
Net Margin % 1223,1 -41,5
Rev Growth 5Y % 18,0 1,8
D/E 0,1 0,3

Objectif de Cours des Analystes

7 analystes
Buy
Actuel
4,91 €
+298.6%
Objectif
19,57 €
13,00 €
20,00 €
28,00 €
Prévisions
P/E Prévisionnel 20,46
BPA Prévisionnel 0,24 €
CA Est. 145,72 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 0,24 €
-0,21 € – 0,63 €
 145,72 M 3
FY2026 -0,91 €
-1,05 € – -0,79 €
 66,43 M 3

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,37 € -0,37 € +2,2%
Q32025 -0,34 € -0,11 € +68,5%
Q22025 -0,39 € -0,47 € -19,0%
Q12025 -0,35 € -0,24 € +32,2%

ETFs Holding This Stock

SURI logo SURI Simplify Propel Opportunities ETF
4,27% weight
DTSGX DTSGX
0,03% weight
WSMGX WSMGX
0,03% weight
IRSSX IRSSX
0,01% weight
IIRSX IIRSX
0,01% weight
IRSIX IRSIX
0,01% weight
IRCIX IRCIX
0,01% weight
VVICX VVICX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 66,29% Revenue Growth (3Y) 28,95%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 18,02% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5,82 M Net Income (TTM) 71,18 M
ROE 42,52% ROA 29,83%
Gross Margin N/A Operating Margin -1536,91%
Net Margin 1223,08% Free Cash Flow (TTM) -84,30 M
ROIC -42,47% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,12 Current Ratio 9,74
Interest Coverage -23,92 Asset Turnover 0,02
Working Capital 193,95 M Tangible Book Value 171,23 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 4,14 Forward P/E N/A
P/B Ratio 1,72 P/S Ratio 50,63
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -28,61%
Market Cap 294,66 M Enterprise Value 231,53 M
Per Share
EPS (Diluted TTM) 1,01 Revenue / Share 0,10
FCF / Share -1,48 OCF / Share -1,34
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 137,03% FCF Conversion -118,43%
SBC-Adj. FCF -94,33 M Growth Momentum 48,27

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5,82 M 3,50 M 3,50 M 1,41 M 3,00 M
Net Income 71,18 M -63,73 M -54,19 M -39,70 M -84,94 M
EPS (Diluted) 1,01 -1,55 -2,53 — —
Gross Profit — — — — —
Operating Income -89,45 M -64,21 M -47,14 M -50,92 M -89,84 M
EBITDA — — — — —
R&D Expenses 26,81 M 34,36 M 31,09 M 28,97 M 34,33 M
SG&A Expenses 65,03 M — — — —
D&A 2,55 M 2,00 M 2,29 M 3,09 M 3,25 M
Interest Expense 3,74 M 4,21 M 418 000,0 736 000,0 3,67 M
Income Tax 100 000,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 219,57 M 108,93 M 64,00 M 64,21 M 79,59 M
Total Liabilities 60,35 M 64,90 M 49,18 M 37,45 M 28,21 M
Shareholders' Equity 159,22 M 44,03 M 14,83 M 26,76 M 51,38 M
Total Debt 20,04 M 18,96 M — — —
Cash & Equivalents 78,44 M 23,36 M 14,47 M 14,22 M 32,94 M
Current Assets 204,91 M 100,85 M 55,74 M 53,10 M 55,40 M
Current Liabilities 29,57 M 16,59 M 13,42 M 7,78 M 16,62 M